AMAN SHAMAA: Open Payments
NPI 1902326739 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,781 in 70 payments from 30 companies in 2025. Trend: 2023 $2,544 · 2024 $1,566 · 2025 $2,781
Food & beverage: $2,510Education: $271
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $601 |
| Astellas Pharma US Inc | 9 | $351 |
| Janssen Biotech, Inc. | 11 | $314 |
| GlaxoSmithKline, LLC. | 4 | $158 |
| Incyte Corporation | 2 | $155 |
| ABBVIE INC. | 4 | $155 |
| Aveo Pharmaceuticals, Inc. | 3 | $112 |
| BeOne Medicines USA, Inc. | 2 | $110 |
| E.R. Squibb & Sons, L.L.C. | 1 | $108 |
| Tactile Systems Technology Inc | 1 | $97 |
Products named: TEZSPIRE, Vyloy, Jakafi, RYBREVANT, OPDIVO, CREON, ZEJULA, DARZALEX.
Industry payments across CA — which companies pay providers there.
